• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Gut Microbes . Gastrointestinal microbiota and metabolites possibly contribute to distinct pathogenicity of SARS-CoV-2 proto or its variants in rhe

tetano

Editor, Senior Moderator
Gut Microbes


. 2024 Jan-Dec;16(1):2334970.
doi: 10.1080/19490976.2024.2334970. Epub 2024 Apr 2. Gastrointestinal microbiota and metabolites possibly contribute to distinct pathogenicity of SARS-CoV-2 proto or its variants in rhesus monkeys

Hongyu Chen[SUP] 1 [/SUP], Junbin Wang[SUP] 1 [/SUP], Kaiyun Ding[SUP] 1 [/SUP], Jingwen Xu[SUP] 1 [/SUP], Yun Yang[SUP] 1 [/SUP], Cong Tang[SUP] 1 [/SUP], Yanan Zhou[SUP] 1 [/SUP], Wenhai Yu[SUP] 1 [/SUP], Haixuan Wang[SUP] 1 [/SUP], Qing Huang[SUP] 1 [/SUP], Bai Li[SUP] 1 [/SUP], Dexuan Kuang[SUP] 1 [/SUP], Daoju Wu[SUP] 1 [/SUP], Zhiwu Luo[SUP] 1 [/SUP], Jiahong Gao[SUP] 1 [/SUP], Yuan Zhao[SUP] 1 [/SUP], Jiansheng Liu[SUP] 1 [/SUP], Xiaozhong Peng[SUP] 1 2 3 [/SUP], Shuaiyao Lu[SUP] 1 [/SUP], Hongqi Liu[SUP] 1 [/SUP]



Affiliations
Abstract

Gastrointestinal (GI) infection is evidenced with involvement in COVID-19 pathogenesis caused by SARS-CoV-2. However, the correlation between GI microbiota and the distinct pathogenicity of SARS-CoV-2 Proto and its emerging variants remains unclear. In this study, we aimed to determine if GI microbiota impacted COVID-19 pathogenesis and if the effect varied between SARS-CoV-2 Proto and its variants. We performed an integrative analysis of histopathology, microbiomics, and transcriptomics on the GI tract fragments from rhesus monkeys infected with SARS-CoV-2 proto or its variants. Based on the degree of pathological damage and microbiota profile in the GI tract, five of SARS-CoV-2 strains were classified into two distinct clusters, namely, the clusters of Alpha, Beta and Delta (ABD), and Proto and Omicron (PO). Notably, the abundance of potentially pathogenic microorganisms increased in ABD but not in the PO-infected rhesus monkeys. Specifically, the high abundance of UCG-002, UCG-005, and Treponema in ABD virus-infected animals positively correlated with interleukin, integrins, and antiviral genes. Overall, this study revealed that infection-induced alteration of GI microbiota and metabolites could increase the systemic burdens of inflammation or pathological injury in infected animals, especially in those infected with ABD viruses. Distinct GI microbiota and metabolite profiles may be responsible for the differential pathological phenotypes of PO and ABD virus-infected animals. These findings improve our understanding the roles of the GI microbiota in SARS-CoV-2 infection and provide important information for the precise prevention, control, and treatment of COVID-19.

Keywords: COVID-19; SARS-CoV-2; gastrointestinal infection; integrative analysis; microbiota; variant of concern.

 
Back
Top Bottom